By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Oncoceutics 

793 Darby Paoli Road

Bryn Mawr  Pennsylvania  19010-1145  U.S.A.
Phone: 610-800-2443 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Oncoceutics Promotes Lee Schalop, MD, To Chief Operating Officer 11/23/2016 9:45:48 AM
Oncoceutics Release: Imipridone Activity Described In Multiple Abstracts At 2016 American Society of Hematology Meeting 11/16/2016 11:12:36 AM
Oncoceutics Receives Additional US Patent For ONC201 In Adenocarcinomas 9/29/2016 8:47:35 AM
Oncoceutics Release: Oncotarget Article Describes Development Of Imipridone ONC201 9/16/2016 9:14:28 AM
Oncoceutics Release: ONC201 Continues To Show Excellent Safety When Dosed Weekly 9/12/2016 11:05:13 AM
Oncoceutics Awarded FDA Orphan Grant For ONC201 Multiple Myeloma Trial 8/17/2016 1:01:56 PM
ASCO2016: Oncoceutics Release: ONC201 Clinical Trial Results Accepted For 2016 ASCO Poster Discussion 6/1/2016 11:58:53 AM
Oncoceutics Release: ONC201 Clinical Trial Results Accepted For 2016 ASCO Poster Discussion 5/19/2016 2:15:36 PM
Oncoceutics Release: Live Like Bella Childhood Cancer Foundation Approves Grant To CHOP Oncologist To Study ONC201 5/2/2016 1:22:31 PM
Oncoceutics Release: U.S. Patent Issued For ONC201 Composition Of Matter 2/25/2016 1:58:12 PM
123
//-->